Send to

Choose Destination
See comment in PubMed Commons below
Pathol Oncol Res. 2001;7(2):85-94.

Angiogenesis-dependent diseases and angiogenesis therapy.

Author information

National Institute of Oncology, Department of Tumor Progression Ráth Gy. U. 7-9., Budapest, H1122, Hungary. 36 1 224 8786, 36 1 224 8620.


The discovery of the molecular mechanisms of physiological vasculogenesis and pathological angiogenesis helped to recognize two classes of diseases: one where the therapeutic angiogenesis can repair the tissue damages (arteriosclerosis, myocardial infarction, limb ischemia) and the other one where inhibition of pathological angiogenesis can cure the disease or delay its progression (retinopathies, benign and malignant angiogenic tumors, progression of malignant tumors). Although there are an exponentially growing number of new synthetic molecules characterized mainly by antiangiogenic properties, the discovery of a large battery of natural pro- and anti-angiogenic factors suggests that this may provide a more physiological approach to treat both class of angiogenesis-dependent diseases in the near future.

[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Hungarian Oncological Association
    Loading ...
    Support Center